MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/j.1651-2227.1999.tb14422.x

Медицинская библиотека · Acta paediatrica (Oslo, Norway : 1992). Supplement · 1999

Role of oestrogen therapy in the management of short stature in Turner syndrome.

Chernausek S D, Attie K M

СтатьяПеревод в очереди

Аннотация

It is now clear that parenteral growth hormone (GH) therapy stimulates growth and increases the adult stature of girls with Turner syndrome. In addition, oestrogens are given to almost all girls with this syndrome because of primary hypogonadism. Oestrogens influence both growth and maturation of the epiphyseal growth plates. Therefore, the form and timing of oestrogen therapy may have an important impact on the outcome of other growth-promoting therapies. To examine the impact of the timing of oestrogen initiation on growth, a randomized trial was conducted in patients with Turner syndrome who were receiving GH. Some patients received oestrogen at 12 years of age, while in others this treatment was not started until 15 years of age. Those girls that received oestrogen later were significantly taller as adults. The single most important factor in determining height gain appeared to be the number of years of GH therapy prior to the initiation of oestrogen treatment.

Для цитирования: Chernausek S D, Attie K M. Role of oestrogen therapy in the management of short stature in Turner syndrome.. Acta paediatrica (Oslo, Norway : 1992). Supplement. 1999. DOI: 10.1111/j.1651-2227.1999.tb14422.x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.